Browse by UCL people
Group by: Type | Date
Number of items: 80.
2025
Erton, Zeynep Belce;
Leaf, Rebecca K;
de Andrade, Danieli;
Clarke, Ann;
Tektonidou, Maria G;
Pengo, Vittorio;
Sciascia, Savino;
... Erkan, Doruk; + view all
(2025)
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (“Registry”).
Lupus
, 34
(6)
pp. 617-625.
10.1177/09612033251332258.
|
|
Nash, PS;
Dehbi, HM;
Ahmed, N;
Arram, L;
Best, JG;
Balogun, M;
Bennett, K;
... OPTIMAS Investigators; + view all
(2025)
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial.
Stroke
, 56
(8)
pp. 1970-1979.
10.1161/STROKEAHA.125.051457.
|
 |
|
Tohidi-Esfahani, Ibrahim;
Cohen, Hannah;
Ioannou, Yiannis;
Giles, Ian I;
(2025)
Pathogenesis of antiphospholipid antibody syndrome.
In: Wallace, Daniel J and Hahn, Bevra Hannahs and Askanase, Anca and Crow, Mary K and Isenberg, David A and La Cava, Antonio and McMahon, Maureen A and Tsao, Betty P and Venuturupalli, Swamy and Weisman, Michael H, (eds.)
Dubois' Lupus Erythematosus and Related Syndromes.
(pp. 388-401).
Elsevier: Amsterdam, The Netherlands.
|
2024
|
Balbi, Gustavo GM;
Ahmadzadeh, Yasaman;
Tektonidou, Maria G;
Pengo, Vittorio;
Sciascia, Savino;
Ugarte, Amaia;
Belmont, H Michael;
... Oliveira de Andrade, Danieli Castro; + view all
(2024)
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Rheumatology
, 63
(3)
pp. 772-779.
10.1093/rheumatology/kead292.
|
|
Efthymiou, Maria;
Bertolaccini, Maria Laura;
Cohen, Hannah;
(2024)
Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome.
Rheumatology
, 63
(SI)
SI54-SI63.
10.1093/rheumatology/kead623.
|
|
|
Mittal, Prabal;
Gafoor, Rafael;
Sayar, Zara;
Efthymiou, Maria;
Tohidi-Esfahani, Ibrahim;
Appiah-Cubi, Stella;
Arachchillage, Deepa J;
... Cohen, Hannah; + view all
(2024)
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial.
Research and Practice in Thrombosis and Haemostasis
, 8
(5)
, Article e102468. 10.1016/j.rpth.2024.102468.
|
 |
|
Venturelli, Veronica;
Maranini, Beatrice;
Tohidi-Esfahani, Ibrahim;
Isenberg, David A;
Cohen, Hannah;
Efthymiou, Maria;
(2024)
Can complement activation be the missing link in antiphospholipid syndrome?
Rheumatology
, Article keae178. 10.1093/rheumatology/keae178.
(In press).
|
|
Yelnik, CM;
Erton, ZB;
Drumez, E;
Cheildze, D;
de Andrade, D;
Clarke, A;
Tektonidou, MG;
... Erkan, D; + view all
(2024)
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”).
Seminars in Arthritis and Rheumatism
, 65
, Article 152347. 10.1016/j.semarthrit.2023.152347.
|
2023
|
Chighizola, Cecilia B;
Pregnolato, Francesca;
Andrade, Danieli;
Tektonidou, Maria;
Pengo, Vittorio;
Ruiz-Irastorza, Guillermo;
Belmont, H Michael;
... AntiPhospholipid Syndrome Alliance For Clinical Trials and Inter, .; + view all
(2023)
Fluctuation of Anti-Domain 1 and Anti-Β2 Glycoprotein I Antibody Titers Over Time in Patients with Persistently Positive Antiphospholipid Antibodies.
Arthritis & Rheumatology
, 75
(6)
pp. 984-995.
10.1002/art.42459.
|
|
Cohen, Hannah;
Werring, David J;
Chandretheva, Arvind;
Mittal, Prabal;
Devreese, Katrien MJ;
Isenberg, David A;
ISTH SSC LA/aPL Subcommittee Study Group;
(2023)
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Journal of Thrombosis and Haemostasis
, 21
(10)
pp. 2963-2976.
10.1016/j.jtha.2023.06.020.
|
|
Gkrouzman, Elena;
Willis, Rohan;
Andrade, Danieli;
Tektonidou, Maria G;
Pengo, Vittorio;
Ruiz-Irastorza, Guillermo;
Belmont, H Michael;
... APS, ACTION; + view all
(2023)
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
Laboratory Investigation
, 103
(6)
, Article 100147. 10.1016/j.labinv.2023.100147.
|
|
Mendel, R;
Abdelhameed, N;
Salman, RAS;
Cohen, H;
Dowlatshahi, D;
Freemantle, N;
Paciaroni, M;
... Werring, DJ; + view all
(2023)
Prevention of venous thromboembolism in acute spontaneous intracerebral haemorrhage: A survey of opinion.
Journal of the Neurological Sciences
, 454
, Article 120855. 10.1016/j.jns.2023.120855.
|
|
|
Nash, Philip S;
Best, Jonathan G;
Ambler, Gareth;
Wilson, Duncan;
Banerjee, Gargi;
Hostettler, Isabel C;
Seiffge, David;
... CROMIS-2 collaborators; + view all
(2023)
Associations of renal function with cerebral small vessel disease and functional outcome in acute intracerebral haemorrhage: A hospital-based prospective cohort study.
Journal of Neurological Sciences
, 452
, Article 120743. 10.1016/j.jns.2023.120743.
|
|
Zuo, Y;
Navaz, S;
Tsodikov, A;
Kmetova, K;
Kluge, L;
Ambati, A;
Hoy, CK;
... Lockshin, M; + view all
(2023)
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
Arthritis & Rheumatology
10.1002/art.42489.
(In press).
|
|
2022
|
Best, Jonathan G;
Arram, Liz;
Ahmed, Norin;
Balogun, Maryam;
Bennett, Kate;
Bordea, Ekaterina;
Campos, Marta G;
... OPTIMAS investigators, .; + view all
(2022)
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
International Journal of Stroke
, 17
(5)
pp. 583-589.
10.1177/17474930211057722.
|
|
Donnellan, C;
Cohen, H;
Werring, DJ;
(2022)
Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review.
Rheumatology
, 61
(1)
pp. 24-41.
10.1093/rheumatology/keab452.
|
|
Efthymiou, M;
Lane, PJ;
Isenberg, D;
Cohen, H;
Mackie, IJ;
(2022)
Comparison of acquired activated protein C resistance, using the CAT and ST-genesia® analysers and three thrombin generation methods, in APS and SLE patients.
Journal of Clinical Medicine
, 11
(1)
, Article 69. 10.3390/jcm11010069.
|
|
|
Gaspar, Pedro;
Farinha, Filipa;
Sayar, Zara;
Efthymiou, Maria;
Cohen, Hannah;
Isenberg, David A;
(2022)
A one-point increase in the Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality in thrombotic antiphospholipid syndrome.
Clinical and Experimental Rheumatology
10.55563/clinexprheumatol/0gs167.
(In press).
|
|
Hostettler, Isabel Charlotte;
Seiffge, David;
Wong, Andrew;
Ambler, Gareth;
Wilson, Duncan;
Shakeshaft, Clare;
Banerjee, Gargi;
... Werring, David; + view all
(2022)
APOE and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage.
Neurology
, 99
(12)
e1290-e1298.
10.1212/WNL.0000000000200851.
|
|
Schwarz, G;
Banerjee, G;
Hostettler, IC;
Ambler, G;
Seiffge, DJ;
Ozkan, H;
Browning, S;
... Werring, DJ; + view all
(2022)
MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.
International Journal of Stroke
10.1177/17474930211062478.
(In press).
|
|
|
Sevim, E;
Zisa, D;
Andrade, D;
Sciascia, S;
Pengo, V;
Tektonidou, MG;
Ugarte, A;
... APS ACTION Investigators; + view all
(2022)
Characteristics of Antiphospholipid Antibody Positive Patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking.
Arthritis Care & Research
, 74
(2)
pp. 324-335.
10.1002/acr.24468.
|
2021
|
Almarzouki, A;
Wilson, D;
Ambler, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
Al-Shahi Salman, R;
... Werring, DJ; + view all
(2021)
Publisher Correction: Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage.
Scientific Reports
, 11
(1)
, Article 9485. 10.1038/s41598-021-88890-5.
|
|
|
Benjamin, LA;
Paterson, RW;
Moll, R;
Pericleous, C;
Brown, R;
Mehta, PR;
Athauda, D;
... Efthymiou, M; + view all
(2021)
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
EClinicalMedicine
, Article 101070. 10.1016/j.eclinm.2021.101070.
(In press).
|
|
|
Best, JG;
Ambler, G;
Wilson, D;
Lee, K-J;
Lim, J-S;
Shiozawa, M;
Koga, M;
... Werring, DJ; + view all
(2021)
Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
The Lancet Neurology
, 20
(4)
pp. 294-303.
10.1016/S1474-4422(21)00024-7.
|
|
Cohen, H;
Efthymiou, M;
Devreese, KMJ;
(2021)
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
Journal of Thrombosis and Haemostasis
, 19
(4)
pp. 892-908.
10.1111/jth.15217.
|
|
Cohen, H;
Isenberg, DA;
(2021)
How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
Blood
, 137
(3)
pp. 299-309.
10.1182/blood.2020004942.
|
|
Du, H;
Wilson, D;
Ambler, G;
Banerjee, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
... Clinical Relevance of Microbleeds in Stroke (CROMIS-2) Collabora, .; + view all
(2021)
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.
Stroke
, 52
(1)
pp. 91-99.
10.1161/STROKEAHA.120.029474.
|
|
Gkrouzman, E;
Sevim, E;
Finik, J;
Andrade, D;
Pengo, V;
Sciascia, S;
Tektonidou, MG;
... APS ACTION+; + view all
(2021)
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results from APS ACTION Clinical Database and Repository.
Journal of Rheumatology
, 48
(4)
pp. 541-547.
10.3899/jrheum.200513.
|
|
Hostettler, IC;
Schwarz, G;
Ambler, G;
Wilson, D;
Banerjee, G;
Seiffge, D;
Shakeshaft, C;
... Werring, DJ; + view all
(2021)
Cerebral Small Vessel Disease and Functional Outcome Prediction after Intracerebral Haemorrhage.
Neurology
, 96
(15)
e1954-e1965.
10.1212/WNL.0000000000011746.
|
|
Munoz, CM;
Ahmed, K;
Thomas, M;
Cohen, H;
Alijotas-Reig, J;
Giles, I;
(2021)
Comparing pregnancy outcomes in patients with criteria and non-criteria autoimmune disease: A systematic review.
Lupus
10.1177/09612033211061850.
(In press).
|
  |
|
Paterson, RW;
Benjamin, LA;
Mehta, PR;
Brown, RL;
Athauda, D;
Ashton, NJ;
Leckey, CA;
... Schott, JM; + view all
(2021)
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Brain Communications
, 3
(3)
, Article fcab099. 10.1093/braincomms/fcab099.
|
|
|
Ramirez, GA;
Mackie, I;
Nallamilli, S;
Pires, T;
Moll, R;
Pericleous, C;
Isenberg, DA;
... Efthymiou, M; + view all
(2021)
Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
Rheumatology
, 60
(3)
pp. 1376-1386.
10.1093/rheumatology/keaa509.
|
|
Sayar, Z;
Moll, R;
Isenberg, D;
Cohen, H;
(2021)
Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management.
Thrombosis Research
, 198
pp. 213-221.
10.1016/j.thromres.2020.10.010.
|
|
|
Sayar, Z;
Nallamilli, S;
Efthymiou, M;
Lambert, J;
Cohen, H;
(2021)
Coexistent antiphospholipid syndrome and myeloproliferative neoplasm.
Lupus
, 30
(9)
pp. 1502-1508.
10.1177/09612033211021154.
|
|
|
Seiffge, DJ;
Wilson, D;
Ambler, G;
Banerjee, G;
Hostettler, IC;
Houlden, H;
Shakeshaft, C;
... Werring, DJ; + view all
(2021)
Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-325299.
(In press).
|
|
2020
|
Aad, G;
Abbott, B;
Abbott, DC;
Abdinov, O;
Abud, AA;
Abeling, K;
Abhayasinghe, DK;
... Pereira, RA; + view all
(2020)
Search for electroweak production of charginos and sleptons decaying into final states with two leptons and missing transverse momentum in √s=13 TeV pp collisions using the ATLAS detector.
European Physical Journal C
, 80
, Article 123. 10.1140/epjc/s10052-019-7594-6.
|
|
|
Almarzouki, A;
Wilson, D;
Ambler, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
Salman, RA-S;
... Werring, DJ; + view all
(2020)
Sensitivity and specifcity of blood‑fuid levels for oral anticoagulant‑associated intracerebral haemorrhage.
Scientific Reports
, 10
(1)
, Article 15529. 10.1038/s41598-020-72504-7.
|
|
|
Banerjee, G;
Ambler, G;
Wilson, D;
Hostettler, IC;
Shakeshaft, C;
Lunawat, S;
Cohen, H;
... CROMIS-2 collaborators, .; + view all
(2020)
Baseline factors associated with early and late death in intracerebral haemorrhage survivors.
European Journal of Neurology
, 27
(7)
pp. 1257-1263.
10.1111/ene.14238.
|
|
|
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... CROMIS‐2 Collaborators, *; + view all
(2020)
Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations.
Journal of the American Heart Association
, 9
(1)
, Article e014537. 10.1161/JAHA.119.014537.
|
|
|
Banerjee, G;
Wilson, D;
Ambler, G;
Hostettler, IC;
Shakeshaft, C;
Cohen, H;
Yousry, T;
... CROMIS-2 collaborators; + view all
(2020)
Longer term stroke risk in intracerebral haemorrhage survivors.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323079.
(In press).
|
|
|
Best, JG;
Barbato, C;
Ambler, G;
Du, H;
Banerjee, G;
Wilson, D;
Shakeshaft, C;
... Clinical Relevance of Microbleeds in Stroke (CROMIS-2) collabora; + view all
(2020)
Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage.
Neurology
10.1212/WNL.0000000000010788.
(In press).
|
|
|
Beyrouti, R;
Adams, ME;
Benjamin, L;
Cohen, H;
Farmer, SF;
Goh, YY;
Humphries, F;
... Werring, DJ; + view all
(2020)
Characteristics of ischaemic stroke associated with COVID-19.
[Letter].
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323586.
(In press).
|
|
|
Cohen, H;
Cuadrado, MJ;
Erkan, D;
Duarte-Garcia, A;
Isenberg, DA;
Knight, JS;
Ortel, TL;
... Andrade, D; + view all
(2020)
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
Lupus
, 29
(12)
pp. 1571-1593.
10.1177/0961203320950461.
|
|
Cohen, H;
Sayar, Z;
Efthymiou, M;
Gaspar, P;
Richards, T;
Isenberg, D;
(2020)
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome.
The Lancet Haematology
, 7
(8)
e613-e623.
10.1016/S2352-3026(20)30116-2.
|
|
Gaspar, P;
Cohen, H;
Isenberg, DA;
(2020)
The assessment of patients with the antiphospholipid antibody syndrome: where are we now?
Rheumatology
, 59
(7)
pp. 1489-1494.
10.1093/rheumatology/keaa172.
|
|
Hostettler, IC;
Morton, MJ;
Ambler, G;
Kazmi, N;
Gaunt, T;
Wilson, D;
Shakeshaft, C;
... CROMIS-2 collaborators; + view all
(2020)
Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage.
Journal of Neurology, Neurosurgery and Psychiatry
, 91
(3)
pp. 298-304.
10.1136/jnnp-2019-321774.
|
|
|
Mc Lernon, S;
Schwarz, G;
Wilson, D;
Ambler, G;
Goodwin, R;
Shakeshaft, C;
Cohen, H;
... CROMIS-2 Collaborators; + view all
(2020)
Association between critical care admission and 6-month functional outcome after spontaneous intracerebral haemorrhage.
Journal of the Neurological Sciences
, 418
, Article 117141. 10.1016/j.jns.2020.117141.
|
|
Schreiber, K;
Sciascia, S;
Bruce, IN;
Giles, I;
Cuadrado, MJ;
Cohen, H;
Gordon, C;
... Hunt, BJ; + view all
(2020)
Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians.
The Lancet Rheumatology
10.1016/S2665-9913(20)30382-9.
(In press).
|
|
|
Ulivi, L;
Squitieri, M;
Cohen, H;
Cowley, P;
Werring, DJ;
(2020)
Cerebral venous thrombosis: a practical guide.
Practical Neurology
, 20
(5)
pp. 356-367.
10.1136/practneurol-2019-002415.
|
|
Zuily, S;
Cohen, H;
Isenberg, D;
Woller, SC;
Crowther, M;
Dufrost, V;
Wahl, D;
... Devreese, KMJ; + view all
(2020)
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
J Thromb Haemost
, 18
(9)
pp. 2126-2137.
10.1111/jth.14935.
|
|
Zuily, S;
Clerc-Urmes, I;
Bauman, C;
Andrade, D;
Sciascia, S;
Pengo, V;
Tektonidou, MG;
... Erkan, D; + view all
(2020)
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Lupus
, 29
(11)
pp. 1353-1363.
10.1177/0961203320940776.
|
|
2019
|
Aaboud, M;
Aad, G;
Abbott, B;
Abdinov, O;
Abeloos, B;
Abhayasinghe, DK;
Abidi, SH;
... Zwalinski, L; + view all
(2019)
Searches for scalar leptoquarks and differential cross-section measurements in dilepton-dijet events in proton-proton collisions at a centre-of-mass energy of root s=13TeV with the ATLAS experiment.
The European Physical Journal C
, 79
, Article 733. 10.1140/epjc/s10052-019-7181-x.
|
|
|
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... Vahidassr, D; + view all
(2019)
Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA.
Journal of Neurology
, 266
(5)
pp. 1250-1259.
10.1007/s00415-019-09256-6.
|
|
|
Cohen, H;
Mackie, IJ;
Devreese, KMJ;
(2019)
Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey.
Journal of Thrombosis and Haemostasis
, 17
(10)
pp. 1715-1732.
10.1111/jth.14560.
|
|
Efthymiou, M;
Mackie, IJ;
Lane, PJ;
Andrade, D;
Willis, R;
Erkan, D;
Sciascia, S;
... APS ACTION, .; + view all
(2019)
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Journal of Thrombosis and Haemostasis
, 17
(12)
pp. 2069-2080.
10.1111/jth.14596.
|
|
Hostettler, IC;
Bernal-Quiros, M;
Wong, A;
Sharma, N;
Wilson, D;
Seiffge, D;
Shakeshaft, C;
... Houlden, H; + view all
(2019)
C9orf72 and intracerebral haemorrhage.
Neurobiology of Aging
, 84
237.e1-237.e3.
10.1016/j.neurobiolaging.2019.07.007.
|
|
McDonnell, T;
Wincup, C;
Buchholz, I;
Pericleous, C;
Giles, I;
Ripoll, V;
Cohen, H;
... Rahman, A; + view all
(2019)
The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS.
Blood Reviews
, Article 100610. 10.1016/j.blre.2019.100610.
|
|
|
Radin, M;
Sciascia, S;
Erkan, D;
Pengo, V;
Tektonidou, MG;
Ugarte, A;
Meroni, P;
... APS ACTION; + view all
(2019)
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Seminars in Arthritis and Rheumatism
, 49
(3)
pp. 464-468.
10.1016/j.semarthrit.2019.04.009.
|
|
Ramirez, GA;
Efthymiou, M;
Isenberg, DA;
Cohen, H;
(2019)
Under crossfire: thromboembolic risk in systemic lupus erythematosus.
Rheumatology
, 58
(6)
pp. 940-952.
10.1093/rheumatology/key307.
|
|
Sciascia, S;
Willis, R;
Pengo, V;
Krilis, S;
Andrade, D;
Tektonidou, MG;
Ugarte, A;
... APS ACTION, .; + view all
(2019)
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
Thrombosis Research
, 175
pp. 32-36.
10.1016/j.thromres.2019.01.010.
|
|
Wilson, D;
Ambler, G;
Lee, K-J;
Lim, J-S;
Shiozawa, M;
Koga, M;
Li, L;
... Microbleeds International Collaborative Network, .; + view all
(2019)
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
Lancet Neurology
10.1016/S1474-4422(19)30197-8.
(In press).
|
|
|
Wilson, D;
Ambler, G;
Shakeshaft, C;
Banerjee, G;
Charidimou, A;
Seiffge, D;
White, M;
... CROMIS-2 collaborators, .; + view all
(2019)
Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA.
BMJ Open
, 9
(7)
, Article e028387. 10.1136/bmjopen-2018-028387.
|
|
2018
|
Cohen, H;
Efthymiou, M;
Gates, C;
Isenberg, D;
(2018)
Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome.
Seminars in Thrombosis and Hemostasis
, 44
(05)
pp. 427-438.
10.1055/s-0036-1597902.
|
|
|
Cohen, H;
Efthymiou, M;
Isenberg, DA;
(2018)
Use of direct oral anticoagulants in antiphospholipid syndrome.
Journal of Thrombosis and Haemostasis
, 16
(6)
pp. 1028-1039.
10.1111/jth.14017.
|
|
Efthymiou, M;
Arachchillage, DRJ;
Lane, PJ;
O'Keeffe, AG;
McDonnell, T;
Cohen, H;
Mackie, IJ;
(2018)
Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.
Thrombosis Research
, 170
pp. 60-68.
10.1016/j.thromres.2018.08.003.
|
|
Ramirez, G;
Cohen, H;
Mackie, I;
Isenberg, D;
Efthymiou, M;
(2018)
Prevalence of anti-protein C antibodies and acquired activated protein C resistance and in systemic lupus erythematosus.
Presented at: British Society for Haemostasis and Thrombosis, Coventry, UK.
|
|
|
Wilson, D;
Ambler, G;
Banerjee, G;
Shakeshaft, C;
Cohen, H;
Yousry, TA;
Al-Shahi Salman, R;
... Werring, DJ; + view all
(2018)
Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(3)
pp. 320-325.
10.1136/jnnp-2018-318890.
|
|
Wilson, D;
Ambler, G;
Shakeshaft, C;
Brown, MM;
Charidimou, A;
Salman, RA-S;
Lip, GYH;
... Werring, DJ; + view all
(2018)
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
The Lancet Neurology
, 17
(6)
pp. 539-547.
10.1016/S1474-4422(18)30145-5.
|
|
2017
|
Banerjee, G;
Wilson, D;
Ambler, G;
Osei-Bonsu Appiah, K;
Shakeshaft, C;
Lunawat, S;
Cohen, H;
... CROMIS-2 Collaborators; + view all
(2017)
Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy.
Stroke
, 49
pp. 40-45.
10.1161/STROKEAHA.117.019409.
|
|
|
Efthymiou, M;
Mackie, IJ;
Lane, P;
Erkan, D;
Cohen, H;
(2017)
High prevalence of activated protein C resistance associated with high avidity anti-protein C antibodies in various antiphospholipid syndrome clinical phenotypes.
In:
(Proceedings) ISTH 2017.
|
|
2016
|
Arachchillage, DRJ;
Mackie, IJ;
Efthymiou, M;
Chitolie, A;
Hunt, BJ;
Isenberg, DA;
Khamashta, M;
... Cohen, H; + view all
(2016)
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
Journal of Thrombosis and Haemostasis
, 14
(11)
pp. 2177-2186.
10.1111/jth.13475.
|
|
|
Cohen, H;
Hunt, BJ;
Efthymiou, M;
Arachchillage, DR;
Mackie, IJ;
Clawson, S;
Sylvestre, Y;
... RAPS trial investigators, .; + view all
(2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Lancet Haematology
, 3
(9)
e426-e436.
10.1016/S2352-3026(16)30079-5.
|
|
|
Engert, A;
Balduini, C;
Brand, A;
Coiffier, B;
Cordonnier, C;
Doehner, H;
de Wit, TD;
... Zieger, B; + view all
(2016)
The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Haematologica
, 101
(2)
pp. 115-208.
10.3324/haematol.2015.136739.
|
2015
|
Cohen, H;
Doré, CJ;
Clawson, S;
Hunt, BJ;
Isenberg, D;
Khamashta, M;
Muirhead, N;
(2015)
Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Lupus
, 24
(10)
pp. 1087-1094.
10.1177/0961203315581207.
|
|
|
Cohen, H;
Hunt, B;
Efythymiou, M;
Arachchillage, D;
Ruiz, M;
Clawson, S;
Muirhead, N;
... Collaborators, RAPST; + view all
(2015)
Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Journal of Thrombosis and Haemostasis
, 13
, Article LB003. DOI: 10.1111/jth.12993.
|
|
Wilson, D;
Charidimou, A;
Shakeshaft, C;
Ambler, G;
White, M;
Cohen, H;
Yousry, T;
... Werring, DJ; + view all
(2015)
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type.
Neurology
, 86
(4)
pp. 360-366.
10.1212/WNL.0000000000002310.
|
|
2013
|
Gardiner, C;
Hills, J;
Machin, SJ;
Cohen, H;
(2013)
Diagnosis of antiphospholipid syndrome in routine clinical practice.
Lupus
, 22
(1)
18 - 25.
10.1177/0961203312460722.
|
|
2011
|
Kasperavičiute, D;
Catarino, CB;
Chinthapalli, K;
Clayton, LMS;
Thom, M;
Martinian, L;
Cohen, H;
... Sisodiya, SM; + view all
(2011)
Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions.
PLoS ONE
, 6
(8)
, Article e23182. 10.1371/journal.pone.0023182.
|
|
2009
|
Gardiner, C;
Longair, I;
Pescott, MA;
Erwin, H;
Hills, J;
Machin, SJ;
Cohen, H;
(2009)
Self-monitoring of oral anticoagulation: does it work outside trial conditions?
Journal of Clinical Pathology
, 62
(2)
168 - 171.
10.1136/jcp.2008.059634.
|
1989
|
Cohen, H;
(1989)
Haemostatic changes in renal allograft recipients and the role of cyclosporin.
Masters thesis , University of Manchester.
|
